Segall Bryant & Hamill, LLC Blueprint Medicines Corp Transaction History

Segall Bryant & Hamill, LLC

$7.07 Billion
Q4 2024

A detailed history of Segall Bryant & Hamill, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 139,743 shares of BPMC stock, worth $12.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

139,743

Previous 141,622 1.33%

Holding current value

$12.6 Million

Previous $13.1 Million 6.92%

% of portfolio

0.17%

Previous 0.18%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$82.48 - $101.39 $154,979 - $190,511	-1,879 Reduced 1.33%	139,743 $12.2 Million
Q3 2024 Nov 08, 2024	BUY	$84.1 - $120.5 $1.23 Million - $1.77 Million	14,668 Added 11.55%	141,622 $13.1 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $294,467 - $376,052	3,457 Added 2.8%	126,954 $13.7 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $128,193 - $174,832	-1,752 Reduced 1.4%	123,497 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $1.32 Million - $2.79 Million	30,099 Added 31.63%	125,249 $11.6 Million
Q3 2023 Nov 09, 2023	SELL	$46.9 - $66.0 $26,310 - $37,026	-561 Reduced 0.59%	95,150 $4.78 Million
Q2 2023 Aug 11, 2023	BUY	$42.2 - $66.37 $22,408 - $35,242	531 Added 0.56%	95,711 $6.05 Million
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $3.32 Million - $4.37 Million	-87,480 Reduced 47.89%	95,180 $4.28 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $7.5 Million - $12.1 Million	182,660 New	182,660 $8 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $10.4 Million - $16.2 Million	208,631 New	208,631 $13.7 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $1.3 Million - $2.02 Million	28,752 Added 16.39%	204,188 $10.3 Million
Q1 2022 May 13, 2022	BUY	$54.1 - $110.08 $6.31 Million - $12.8 Million	116,602 Added 198.19%	175,436 $11.2 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $1.46 Million - $1.8 Million	15,498 Added 35.76%	58,834 $6.3 Million
Q3 2021 Nov 03, 2021	BUY	$80.98 - $109.47 $92,803 - $125,452	1,146 Added 2.72%	43,336 $4.46 Million
Q2 2021 Aug 12, 2021	BUY	$82.78 - $101.0 $211,668 - $258,257	2,557 Added 6.45%	42,190 $3.71 Million
Q1 2021 May 13, 2021	SELL	$90.71 - $108.28 $63,587 - $75,904	-701 Reduced 1.74%	39,633 $3.85 Million
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $68,967 - $93,235	-749 Reduced 1.82%	40,334 $4.52 Million
Q3 2020 Nov 13, 2020	BUY	$66.45 - $92.7 $1.98 Million - $2.76 Million	29,755 Added 262.67%	41,083 $3.81 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $19,410 - $26,951	340 Added 3.09%	11,328 $883,000
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $52,632 - $89,948	-1,094 Reduced 9.05%	10,988 $642,000
Q4 2019 Feb 11, 2020	BUY	$66.73 - $82.59 $806,231 - $997,852	12,082 New	12,082 $967,000

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account

Segall Bryant & Hamill, LLC Blueprint Medicines Corp Transaction History